Catalog No.
RHD66401
Species reactivity
Rat
Host species
Rabbit
Isotype
IgG
Clonality
Monoclonal
Tested applications
WB: 1:500-1:1000
Target
MPZ, Myelin protein zero, Myelin protein P0, Myelin peripheral protein, MPP
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P25189
Applications
WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.
Clone ID
R1S78
A dose escalation and safety study of AAVrh10-mediated Schwann cell-targeted gene therapy for CMT1X., PMID:40055046
Mepolizumab efficacy and safety in patients with eosinophilic granulomatosis with polyangiitis in real practice: Data from a Spanish retrospective multicentric register from Rheumatology departments., PMID:39894626
Long-term efficacy of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: a propensity score matching analysis in the multicenter REVEAL cohort study., PMID:39416779
Three cases of relapsed eosinophilic sinusitis without eosinophilia during mepolizumab maintenance therapy for eosinophilic granulomatosis with polyangiitis., PMID:39249645
Augmentation of functional recovery via ROCK/PI3K/AKT pathway by Fasudil Hydrochloride in a rat sciatic nerve transection model., PMID:39007038
Veno-Occlusive Disease: A Life-saving Novel Approach With Plasma Exchange, IVIG, and Steroid, Without Defibrotide., PMID:38810004
Factors associated with drug retention of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: A multicentre REVEAL cohort study., PMID:38727536
Intravenous immunoglobulin preparations attenuate lysolecithin-induced peripheral demyelination in mice and comprise anti-large myelin protein zero antibody., PMID:36775342
Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study., PMID:35768825
A patient with eosinophilic granulomatosis with polyangiitis successfully weaned from corticosteroids through remission induction therapy with mepolizumab., PMID:35366318
Myelin Protein Zero Immunohistochemistry Is Not a Reliable Marker of Extrinsic Mucosal Innervation in Patients With Hirschsprung Disease., PMID:34904460
Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis., PMID:34473835
Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice., PMID:34406911
Multi-targeted therapy for refractory eosinophilic granulomatosis with polyangiitis characterized by intracerebral hemorrhage and cardiomyopathy: a case-based review., PMID:34287685
Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis., PMID:33726827
Anti-P0 Antibody-Conjugated Nanoscale Contrast Agent Targeting the Myelin Sheath for Intraoperative Visible Delineation of Cranial Nerves., PMID:33455377
FGF21 impedes peripheral myelin development by stimulating p38 MAPK/c-Jun axis., PMID:32657446
Myelination during fracture healing in vivo in myelin protein zero (p0) transgenic medaka line., PMID:31923703
Membranous Nephropathy in a Patient with Charcot-Marie-Tooth Disease: Association of Myelin Mutations., PMID:30271005
Characterization of spinal cord glial cells in a model of hindlimb unloading in mice., PMID:25218808
Biologics for ANCA-associated vasculitis., PMID:24998311
Costimulatory molecule CD40 is essential for myelin protein 0 peptide 106-125-induced experimental autoimmune neuritis in mice., PMID:24709684
Myelination of the postnatal mouse cochlear nerve at the peripheral-central nervous system transitional zone., PMID:24400289
CD19 as a therapeutic target in a spontaneous autoimmune polyneuropathy., PMID:24116957
Major isoform of zebrafish P0 is a 23.5 kDa myelin glycoprotein expressed in selected white matter tracts of the central nervous system., PMID:21452240
Embryonic corneal Schwann cells express some Schwann cell marker mRNAs, but no mature Schwann cell marker proteins., PMID:19387082
Axonal neuropathy due to myelin protein zero mutation misdiagnosed as amyloid neuropathy., PMID:18563718
Antibodies to myelin protein zero (P0) protein as markers of auto-immune inner ear diseases., PMID:17453719
Glomerular permeability is altered by loss of P0, a myelin protein expressed in glomerular epithelial cells., PMID:16162811
Investigation of serum response to PMP22, connexin 32 and P(0) in inflammatory neuropathies., PMID:11438177
Protein conformation and disease: pathological consequences of analogous mutations in homologous proteins., PMID:11112514
Expression analysis of the PMP22 gene in glioma and osteogenic sarcoma cell lines., PMID:10561690
For research use only. Not for human or drug use.
